APHD VERDE BIO HOLDINGS, INC.
Crude Petroleum & Natural Gas · OTC · SEC CIK 1490054 · Fiscal year ends 04/30
Financial factors as of 2024-01-31 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-45.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-190.1%
ROA-85.1%
ROIC (approx.)-83.9%
Asset turnover—
Leverage & solvency
Liabilities / assets84.8%
Debt / equity0.00x
Current ratio—
Interest coverage-38.29x
Cash quality & payout
Operating cash flow / net income0.42x
Accruals ratio-49.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-04-30 | FY20222022-04-30 | FY20212021-04-30 | FY2020*2020-04-30 | FY2019*2019-04-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | $0 |
| Cost of revenue | — | — | — | — | $0 |
| Gross profit | — | — | -$1,665 | $0 | $0 |
| SG&A expense | — | — | — | — | $14,014 |
| Operating income | -$1.64M | -$3.15M | -$2.97M | -$259,217 | -$37,081 |
| Interest expense | $65,878 | $0 | $366,057 | $231,658 | $350,326 |
| Pretax income | -$1.77M | -$3.42M | -$3.31M | -$1.58M | -$537,087 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$1.86M | -$3.44M | $0 | -$1.58M | -$537,087 |
| EBITDA | -$1.58M | -$3.12M | -$2.97M | -$259,217 | — |
| EPS (basic) | — | 0.00 | -0.03 | -1.03 | -0.01 |
| EPS (diluted) | — | 0.00 | -0.03 | -1.03 | -0.53 |
| Weighted avg. shares (diluted) | — | 1.14B | 94.79M | 1.53M | 1.02M |
| Banking | |||||
| Provision for credit losses | — | — | $42,556 | $21,563 | $6,000 |
| Balance sheet | |||||
| Cash & equivalents | $25,836 | $141,206 | $2.09M | $1,631 | $23,752 |
| Receivables | $71,912 | — | — | — | $0 |
| Current assets | $97,748 | $295,873 | $2.21M | $1,631 | — |
| PP&E, net | $2.72M | $2.78M | $0 | — | — |
| Total assets | $4.16M | $5.09M | $3.22M | $1,631 | $23,752 |
| Current liabilities | $1.84M | $1.45M | $484,014 | $3.14M | — |
| Total liabilities | $1.84M | $1.47M | $562,242 | $3.14M | $2.03M |
| Shareholders' equity | $2.21M | $3.59M | $2.66M | -$3.13M | -$2.01M |
| Shares outstanding | 1.54B | 1.18B | 683.08M | 1.83M | 1.07M |
| Cash flow statement | |||||
| Operating cash flow | -$872,226 | -$1.15M | -$685,159 | -$177,751 | -$16,377 |
| Capital expenditure | $6,985 | $2.87M | — | — | — |
| Free cash flow | -$879,211 | -$4.02M | — | — | — |
| Investing cash flow | $148,015 | -$5.68M | -$2.50M | $0 | — |
| Financing cash flow | $608,841 | $4.88M | $5.27M | $155,630 | $30,000 |
| Depreciation & amortization | $61,583 | $25,874 | $0 | $0 | — |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.